HUMAN METAPNEUMOVIRUS IMMUNIZATION

Clinical trials for HUMAN METAPNEUMOVIRUS IMMUNIZATION explained in plain language.

Never miss a new study

Get alerted when new HUMAN METAPNEUMOVIRUS IMMUNIZATION trials appear

Sign up with your email to follow new studies for HUMAN METAPNEUMOVIRUS IMMUNIZATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New Two-in-One shot aims to shield seniors from dangerous viruses

⭐️ VACCINE ⭐️ Ongoing

This study is testing a new mRNA vaccine designed to protect adults aged 60 and older from two common respiratory viruses: human metapneumovirus (hMPV) and respiratory syncytial virus (RSV). Researchers will give the vaccine to about 1,530 participants to check how safe it is and…

Matched conditions: HUMAN METAPNEUMOVIRUS IMMUNIZATION

Phase: PHASE1, PHASE2 • Sponsor: Sanofi Pasteur, a Sanofi Company • Aim: ⭐️ VACCINE ⭐️

Last updated Mar 27, 2026 12:40 UTC

HUMAN METAPNEUMOVIRUS IMMUNIZATION

Get alerted when new HUMAN METAPNEUMOVIRUS IMMUNIZATION trials appear

New Two-in-One shot aims to shield seniors from dangerous viruses